Kiniksa Pharmaceuticals International KNSA Cash Flow Statement (2017-2026)

NASDAQ KNSA
$78.98 -1.82 (-2.25%)
At close: Aug 20, 2026 · 11:49 AM UTC
Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-30.54M-44.08M-25.21M-19.98M224.09M88.53M-12.27M14.97M-13.86M-49.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M14.20M22.59M25.43M
Depreciation and Depletion (Quarter)
0.37M0.38M0.36M0.35M0.18M0.29M0.29M0.29M0.29M0.24M0.15M0.12M0.09M0.09M0.04M0.01M0.03M0.12M0.14M0.17M
Share-based Compensation (Quarter)
6.20M6.13M0.42M0.54M6.04M6.37M0.09M0.16M6.79M7.77M3.61M-0.18M7.83M8.30M7.75M8.88M99.14M10.23M10.06M11.64M
Deferred Taxes (Quarter)
0.35M1.08M-19.44M10.29M-25.71M4.37M10.57M-3.64M0.65M2.99M2.64M4.23M6.06M4.52M2.66M
Cash from Operations (Quarter)
-28.51M-18.88M-36.85M-7.82M62.05M-11.58M-4.27M-3.74M16.99M4.33M3.99M5.17M-2.24M18.77M22.32M28.09M33.68M53.89M50.20M47.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.01M-0.05M-0.16M-0.08M0.12M0.20M1.06M1.15M-1.44M0.30M-0.30M0.19M0.49M-0.82M-0.26M0.84M-0.60M0.93M-1.30M-0.09M
Depreciation & Amortization (CF) (Quarter)
0.66M0.67M0.66M0.65M0.49M0.60M0.60M0.60M0.60M0.54M0.47M0.43M0.40M0.40M0.34M0.36M0.38M0.47M0.47M0.47M
Change in Working Capital
Change in Receivables (Quarter)
0.67M0.69M25.45M-21.63M3.35M1.50M-5.24M17.23M-21.61M18.23M-5.27M4.46M4.44M16.84M-1.66M-8.15M19.83M-36.15M7.63M0.27M
Change in Inventory (Quarter)
-0.78M-1.93M9.55M6.69M-5.29M6.98M1.83M0.53M1.62M5.54M-3.84M7.58M-6.18M-2.32M-4.29M26.11M-6.79M13.50M18.25M-2.21M
Change in Account Payables (Quarter)
-2.54M0.25M1.51M-0.86M-1.05M6.43M-6.51M-0.74M0.36M7.23M-2.66M1.73M0.91M-6.28M0.06M6.93M-2.73M-4.12M22.27M-12.00M
Change in Accured Expenses (Quarter)
-2.46M10.04M4.08M-5.97M1.97M-3.79M-10.65M14.69M7.61M5.29M3.29M18.66M10.80M10.99M-3.60M13.10M8.37M19.63M-5.05M25.79M
Other Working Capital Changes (Quarter)
-0.84M-1.24M12.00M14.29M-14.29M6.66M-1.98M11.23M-8.85M-3.75M13.27M6.99M3.04M5.33M6.87M-2.03M12.32M-13.05M18.57M
Investing Activities
Capital Expenditures (Quarter)
0.78M2.23M-2.75M-0.16M-0.00M0.27M-3.27M0.09M-1.41M3.36M3.84M0.01M2.52M-2.04M0.07M0.14M3.40M0.16M0.66M
Sales of Property, Plant and Equipment (Quarter)
-0.01M0.01M
Change in Acquisitions & Divestments (Quarter)
47.90M10.00M7.50M63.80M36.40M20.10M15.00M73.70M40.83M45.98M61.88M42.44M48.13M87.48M44.03M30.61M84.08M40.78M145.66M36.70M
Cash from Investing Activities (Quarter)
47.85M-50.04M-22.72M38.27M19.04M-42.66M-37.92M35.53M-12.28M-14.89M25.52M-46.80M-6.35M65.29M-51.54M-3.88M-62.76M-70.81M-31.92M-73.58M
Financing Activities
Other financing activities (Quarter)
2.68M1.21M0.99M0.57M0.57M1.29M0.51M0.58M1.66M0.96M3.99M1.14M9.40M2.72M3.18M12.74M16.25M8.58M6.39M17.58M
Cash from Financing Activities (Quarter)
2.68M1.21M0.42M0.54M0.36M1.19M0.09M0.16M0.55M0.69M3.61M-0.18M6.69M2.14M2.77M10.70M11.90M7.66M6.07M12.11M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
22.02M-67.71M-59.15M30.98M81.45M-53.05M-42.10M31.95M5.26M-9.87M33.12M-41.81M-1.90M86.20M-26.45M34.91M-17.18M-9.26M24.36M-14.28M
Free Cash Flow (Quarter)
-29.29M-21.11M-34.09M-7.66M62.05M-11.84M-1.00M-3.83M16.99M5.73M0.62M1.33M-2.25M16.25M24.37M28.02M33.53M50.49M50.04M46.53M
Net Cash Flow (Quarter)
22.02M-67.71M-59.15M30.98M81.45M-53.05M-42.10M31.95M5.26M-9.87M33.12M-41.81M-1.90M86.20M-26.45M34.91M-17.18M-9.26M24.36M-14.28M